Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients
- 1 April 2019
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 15 (4), 177-184
- https://doi.org/10.1200/jop.18.00567
Abstract
Influenza infection causes increased morbidity and higher mortality in patients receiving treatment of underlying cancer, particularly in those with hematological malignancy or patients who have undergone hematopoietic stem-cell transplantation. The illness is characterized by seasonality and nonspecific clinical manifestations of upper respiratory infection at a time when other respiratory illnesses are common in the community, making the diagnosis challenging. However, accurate and timely diagnosis by new molecular techniques is crucial in the management of immunocompromised patients, because delays in initiating appropriate therapy can have devastating consequences. Emergence of viral resistance to currently used antiviral agents is of concern, particularly in immunocompromised hosts, and warrants continued monitoring and surveillance. Early and effective treatment improves outcomes, but optimal therapeutic strategies in patients with cancer are not well defined. Health care and research efforts should focus on defining treatment guidelines in patients with cancer and attempt to improve on current vaccination strategies.Keywords
This publication has 48 references indexed in Scilit:
- Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trialBMJ, 2013
- Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09Clinical Infectious Diseases, 2012
- Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipientsHaematologica, 2011
- How I treat influenza in patients with hematologic malignanciesBlood, 2010
- Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenzaCMAJ : Canadian Medical Association Journal, 2010
- The challenge of respiratory virus infections in hematopoietic cell transplant recipientsBritish Journal of Haematology, 2008
- Influenza vaccination in hematopoietic SCT recipientsBone Marrow Transplantation, 2008
- The benefit of influenza vaccination after bone marrow transplantationBone Marrow Transplantation, 2005
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Low mortality rates related to respiratory virus infections after bone marrow transplantationBone Marrow Transplantation, 2003